Reaction equation
[CH2:1]([C:3]1(O)[C:11]2[C:6](=[CH:7][C:8]([F:12])=[CH:9][CH:10]=2)[CH2:5][CH2:4]1)[CH3:2].[F:14][C:15]1[CH:16]=[CH:17][CH:18]=[C:19]2[C:23]=1[NH:22][CH:21]=[CH:20]2>>[CH2:1]([C:3]1([C:20]2[C:19]3[C:23](=[C:15]([F:14])[CH:16]=[CH:17][CH:18]=3)[NH:22][CH:21]=2)[C:11]2[C:6](=[CH:7][C:8]([F:12])=[CH:9][CH:10]=2)[CH2:5][CH2:4]1)[CH3:2]Participants
3
Procedure
Utilizing 1-ethyl-5-fluoro-indan-1-ol and 7-fluoroindole, the title compound is prepared as in example 1. 217 mg (92%). NMR (400 MHz, CDCl3): δ 0.85 (t, 3H), 2.12 (m, 1H), 2.21 (m, 1H), 2.31 (m, 1H), 2.58 (m, 1H), 2.97 (m, 2H), 6.83 (m, 4H), 6.98 (m, 3H), 8.06 (s, 1H, NH).
Sources & evidence
- ORD record
- ord-b888e303295143afa63cc5b1e99b8fb2
- Source dataset
- uspto-grants-2010_06
- Patent number
- US07728150B2
Linked notes
Loading…